116 related articles for article (PubMed ID: 10188141)
1. Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis.
Pietrzak A; Miturski R; Krasowska D; Postawski K; Lecewicz-Toruń B
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):1-5. PubMed ID: 10188141
[TBL] [Abstract][Full Text] [Related]
2. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Flisiak I; Myśliwiec H; Chodynicka B
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
[TBL] [Abstract][Full Text] [Related]
3. [Influence of dithranol therapy on clinical status and serum calcitonin concentrations in patients with common psoriasis].
Bendkowski W; Hadas E; Swietochowska E; Wielkoszyński T; Ostrowska Z; Szapska B
Pol Merkur Lekarski; 2002 Dec; 13(78):481-3. PubMed ID: 12666446
[TBL] [Abstract][Full Text] [Related]
4. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
[TBL] [Abstract][Full Text] [Related]
5. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
Serwin AB; Wasowicz W; Chodynicka B
Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
[TBL] [Abstract][Full Text] [Related]
6. Serum level of sELAM-1 in psoriatic patients correlates with disease activity.
Krasowska D; Pietrzak A; Lecewicz-Torun B
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):140-2. PubMed ID: 10343943
[TBL] [Abstract][Full Text] [Related]
7. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
8. Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).
Szterling-Jaworowska M; Baran A; Myśliwiec H; Flisiak I
J Dermatolog Treat; 2018 Mar; 29(2):135-139. PubMed ID: 28621164
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment.
Chodorowska G
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):147-51. PubMed ID: 9553912
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
12. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
[TBL] [Abstract][Full Text] [Related]
14. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
15. The impact of the frequency of short contact dithranol treatment.
Prins M; Swinkels OQ; Van de Kerkhof PC; Van der Valk PG
Eur J Dermatol; 2001; 11(3):214-8. PubMed ID: 11358727
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
17. [Soluble tumor-necrosis-factor-alpha receptor type-1 as a marker of activity of psoriasis vulgaris and effects of its treatment].
Serwin AB; Sokołowska M; Chodynicka B
Przegl Lek; 2005; 62(2):95-7. PubMed ID: 16095152
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis.
Regaña MS; Ezquerra GM; Millet PU
Acta Derm Venereol; 2005; 85(5):420-3. PubMed ID: 16159734
[TBL] [Abstract][Full Text] [Related]
19. [Impact of serum epidermal growth factor on progressive psoriasis vulgaris and regulation of Chinese herbal medicine for cleaving heat, cooling blood, and detoxicating on it].
Ma LL; Chen PF; Luo F
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug; 28(8):733-5. PubMed ID: 18928101
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
